The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy.
published in: Kidney International
date of publication: 2016-03-24
language: English
main subject: linagliptin
Cites articles
There is nothing here
Article - wd:Q52853506